Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.

@article{Shelley2011GemcitabineCF,
  title={Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.},
  author={Michael D Shelley and Anne Cleves and Timothy J. Wilt and Malcolm David Mason},
  journal={BJU international},
  year={2011},
  volume={108 2},
  pages={
          168-79
        }
}
  • Michael D Shelley, Anne Cleves, +1 author Malcolm David Mason
  • Published 2011
  • Medicine
  • BJU international
  • OBJECTIVE • To systematically review the literature on gemcitabine chemotherapy for advanced or metastatic bladder cancer. MATERIALS AND METHODS • The Medical Literature Analysis and Retrieval System Onlinedatabase (MEDLINE), the Excerpta Medicadatabase (EMBASE), the Cumulative Index to Nursing and Allied Health Literature database(CIHNAL), the Cochrane database of randomized trials, the Literatura Latino-Americana e do Caribe emCiências da Saúdedatabase (LILACS), and Web of Science were… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 18 CITATIONS

    Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer.

    Bladder Cancer: Diagnosis and Treatment.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    HER2 protein overexpression and gene amplification in upper urinary tract urothelial carcinoma-an analysis of 171 patients.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 84 REFERENCES

    Gemcitabine and paclitaxel chemotherapy as a second-line treatment for advanced or metastatic urothelial carcinoma.